Siemens announced that it has Food and Drug Administration approval for a sliding gantry version of its Somatom Plus 4 CT system, which can be set up in a radiation therapy treatment room to give almost-real-time images to the radiation
Siemens announced that it has Food and Drug Administration approval for a sliding gantry version of its Somatom Plus 4 CT system, which can be set up in a radiation therapy treatment room to give almost-real-time images to the radiation oncologist.
Designed to be used in conjunction with a linear accelerator, the scanner images a patient lying on the treatment table by having the gantry make incremental movements during the scanning process rather than having the table turn, as in a traditional CT setting.
The advantage in having the CT close to the (radiation) delivery machine is that you dont have to reposition the patient (for therapy), said Mark McCarthy, senior product manager in Siemens Oncology Care Systems.
Based on tumor localization data from the scan, the linear accelerator can then almost immediately deliver optimal radiation therapy to the tumor while sparing maximal normal tissue.
Until now, the patient typically was scanned some timeperhaps daysbefore actual therapy, McCarthy said, making it impossible to position the patient in precisely the same location and attitude for therapy. In addition, the tumor may have changed size or position since it was imaged and the patient may have gained or lost weight, all of which detract from accurate treatment.
In theory, this allows you to know where the target is the moment before treatment, McCarthy said. Depending on equipment availability, scans could be repeated at the time of each treatment.
Siemens is installing the combination Somatom Plus 4 with sliding gantry and its Primus linear accelerator at Morristown Memorial Hospital in Morristown, NJ. The project is a collaboration with Dr. James Wong, the hospitals chairman of radiation oncology, and Dr. Minoru Uematsu of the National Defense Medical College in Saitama, Japan.
Now that they have the hardware, the collaborators next goal is to develop a digital interface that will allow automatic targeting of the linear accelerator.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.